Literature DB >> 19477527

The role of the anaphylatoxins in health and disease.

Andreas Klos1, Andrea J Tenner, Kay-Ole Johswich, Rahasson R Ager, Edimara S Reis, Jörg Köhl.   

Abstract

The anaphylatoxin (AT) C3a, C5a and C5a-desArg are generally considered pro-inflammatory polypeptides generated after proteolytic cleavage of C3 and C5 in response to complement activation. Their well-appreciated effector functions include chemotaxis and activation of granulocytes, mast cells and macrophages. Recent evidence suggests that ATs are also generated locally within tissues by pathogen-, cell-, or contact system-derived proteases. This local generation of ATs is important for their pleiotropic biologic effects beyond inflammation. The ATs exert most of the biologic activities through ligation of three cognate receptors, i.e. the C3a receptor, the C5a receptor and the C5a receptor-like, C5L2. Here, we will discuss recent findings suggesting that ATs regulate cell apoptosis, lipid metabolism as well as innate and adaptive immune responses through their impact on antigen-presenting cells and T cells. As we will outline, such regulatory functions of ATs and their receptors play important roles in the pathogenesis of allergy, autoimmunity, neurodegenerative diseases, cancer and infections with intracellular pathogens.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19477527      PMCID: PMC2725201          DOI: 10.1016/j.molimm.2009.04.027

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  261 in total

1.  Identification of four novel human G protein-coupled receptors expressed in the brain.

Authors:  D K Lee; S R George; R Cheng; T Nguyen; Y Liu; M Brown; K R Lynch; B F O'Dowd
Journal:  Brain Res Mol Brain Res       Date:  2001-01-31

2.  G(i)-protein-dependent inhibition of IL-12 production is mediated by activation of the phosphatidylinositol 3-kinase-protein 3 kinase B/Akt pathway and JNK.

Authors:  Andrea la Sala; Massimo Gadina; Brian L Kelsall
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

3.  Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties.

Authors:  Vitaliy Gavrilyuk; Sergey Kalinin; Brian S Hilbush; Andrew Middlecamp; Susan McGuire; Dale Pelligrino; Guy Weinberg; Douglas L Feinstein
Journal:  J Neurochem       Date:  2005-03       Impact factor: 5.372

4.  Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway response.

Authors:  Tao Peng; Liming Hao; Joseph A Madri; Xiao Su; Jack A Elias; Gregory L Stahl; Stephen Squinto; Yi Wang
Journal:  J Clin Invest       Date:  2005-05-12       Impact factor: 14.808

5.  Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase.

Authors:  Rampura T Venkatesha; E Berla Thangam; Asifa K Zaidi; Hydar Ali
Journal:  Mol Immunol       Date:  2005-03       Impact factor: 4.407

6.  Specific detection by flow cytometry of histidine-tagged ligands bound to their receptors using a tag-specific monoclonal antibody.

Authors:  H C Wilken; S Rogge; O Götze; T Werfel; J Zwirner
Journal:  J Immunol Methods       Date:  1999-06-24       Impact factor: 2.303

7.  C5L2, a nonsignaling C5A binding protein.

Authors:  Shoji Okinaga; Dubhfeasa Slattery; Alison Humbles; Zsusanna Zsengeller; Olivier Morteau; Michele Bennett Kinrade; Robbin M Brodbeck; James E Krause; Hye-Ryun Choe; Norma P Gerard; Craig Gerard
Journal:  Biochemistry       Date:  2003-08-12       Impact factor: 3.162

8.  Activation of human neutrophils by C3a and C5A. Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst.

Authors:  M U Ehrengruber; T Geiser; D A Deranleau
Journal:  FEBS Lett       Date:  1994-06-13       Impact factor: 4.124

9.  Cancer and complement.

Authors:  Suzanne Ostrand-Rosenberg
Journal:  Nat Biotechnol       Date:  2008-12       Impact factor: 54.908

10.  An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.

Authors:  Andreas D Niederbichler; Laszlo M Hoesel; Margaret V Westfall; Hongwei Gao; Kyros R Ipaktchi; Lei Sun; Firas S Zetoune; Grace L Su; Saman Arbabi; J Vidya Sarma; Stewart C Wang; Mark R Hemmila; Peter A Ward
Journal:  J Exp Med       Date:  2005-12-27       Impact factor: 14.307

View more
  261 in total

1.  The complement receptor CD46 tips the scales in T(H)1 self-control.

Authors:  Christian M Karsten; Jörg Köhl
Journal:  Nat Immunol       Date:  2010-09       Impact factor: 25.606

Review 2.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

Review 3.  Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.

Authors:  M A Khan; J L Hsu; A M Assiri; D C Broering
Journal:  Clin Exp Immunol       Date:  2015-11-05       Impact factor: 4.330

Review 4.  Complement activation in the context of stem cells and tissue repair.

Authors:  Ingrid U Schraufstatter; Sophia K Khaldoyanidi; Richard G DiScipio
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

Review 5.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

6.  C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy.

Authors:  Lu Liu; Ying Zhang; Ximei Duan; Qi Peng; Quan Liu; Yali Zhou; Songxia Quan; Guolan Xing
Journal:  J Clin Immunol       Date:  2013-12-12       Impact factor: 8.317

7.  Binding of human factor H to outer membrane protein P5 of non-typeable Haemophilus influenzae contributes to complement resistance.

Authors:  Jeroen D Langereis; Marien I de Jonge; Jeffrey N Weiser
Journal:  Mol Microbiol       Date:  2014-08-18       Impact factor: 3.501

8.  Fosb gene products contribute to excitotoxic microglial activation by regulating the expression of complement C5a receptors in microglia.

Authors:  Hiroko Nomaru; Kunihiko Sakumi; Atsuhisa Katogi; Yoshinori N Ohnishi; Kosuke Kajitani; Daisuke Tsuchimoto; Eric J Nestler; Yusaku Nakabeppu
Journal:  Glia       Date:  2014-04-25       Impact factor: 7.452

9.  Brain microvascular endothelial cells exhibit lower activation of the alternative complement pathway than glomerular microvascular endothelial cells.

Authors:  Sarah E Sartain; Nancy A Turner; Joel L Moake
Journal:  J Biol Chem       Date:  2018-03-19       Impact factor: 5.157

10.  Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release.

Authors:  Eivind O Samstad; Nathalie Niyonzima; Stig Nymo; Marie H Aune; Liv Ryan; Siril S Bakke; Knut T Lappegård; Ole-Lars Brekke; John D Lambris; Jan K Damås; Eicke Latz; Tom E Mollnes; Terje Espevik
Journal:  J Immunol       Date:  2014-02-19       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.